166 related articles for article (PubMed ID: 3627817)
1. Synthetic Diosmin in the therapy of venous diseases.
Signorelli S; Ferrara M; Tornetta D; Interlandi S; Amico-Roxas MT; Monaco S; Andreozzi GM
Panminerva Med; 1987; 29(2):165-7. PubMed ID: 3627817
[No Abstract] [Full Text] [Related]
2. [Value of semisynthetic diosmin in chronic venous insufficiency].
Coget JM; Merlen JF
LARC Med; 1982; 2(7):609-10. PubMed ID: 7167035
[No Abstract] [Full Text] [Related]
3. Venous reflux.
Nicolaides AN
Int Angiol; 1989; 8(4 Suppl):5-6. PubMed ID: 2632649
[No Abstract] [Full Text] [Related]
4. Hemorheological improvement after Daflon 500 mg treatment in diabetes.
Lacombe C; Bucherer C; Lelievre JC
Int Angiol; 1988; 7(2 Suppl):21-4. PubMed ID: 3183453
[TBL] [Abstract][Full Text] [Related]
5. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
Tsouderos Y
Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
[TBL] [Abstract][Full Text] [Related]
6. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].
Honorato Pérez J; Arcas Meca R
Rev Med Univ Navarra; 1990; 34(2):77-9. PubMed ID: 2130425
[TBL] [Abstract][Full Text] [Related]
7. Vital capillaroscopy on microcirculation: pharmacodynamic activity of Daflon 500 mg in venous insufficiency.
Balas P; Pagratis N
Int Angiol; 1989; 8(4 Suppl):51-2. PubMed ID: 2632650
[TBL] [Abstract][Full Text] [Related]
8. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
Tsouderos Y
Z Kardiol; 1991; 80 Suppl 7():95-101. PubMed ID: 1792820
[TBL] [Abstract][Full Text] [Related]
9. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
Cospite M; Dominici A
Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs].
De Caprio M; Vinci L; Giumetti D; Colitta G
Clin Ter; 1982 Jun; 101(5):497-508. PubMed ID: 6897029
[No Abstract] [Full Text] [Related]
11. [Clinical evaluation of a new drug in phlebology].
Spartera C; Santoro P; Frezzotti A; Marciani A; Ricci G
Clin Ter; 1979 Jan; 88(2):139-47. PubMed ID: 428194
[No Abstract] [Full Text] [Related]
12. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
Iablokov EG; Bogachev VIu; Domoradskaia AI
Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
Tumino G; Berni A; Tromba L; Marignetti L
Clin Ter; 1987 Aug; 122(3):189-94. PubMed ID: 2973911
[No Abstract] [Full Text] [Related]
14. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
Belcaro G; Rulo A; Candiani C
Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
[TBL] [Abstract][Full Text] [Related]
16. [Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency].
Kirienko AI; Bogachev VIu; Zolotukhin IA; Golovanova OV
Angiol Sosud Khir; 2006; 12(2):73-5. PubMed ID: 17053765
[TBL] [Abstract][Full Text] [Related]
17. [Comparative capillaroscopic study of certain bioflavonoids and total triterpenic fractions of Centella asiatica in venous insufficiency].
Allegra C
Clin Ter; 1984 Sep; 110(6):555-9. PubMed ID: 6238770
[No Abstract] [Full Text] [Related]
18. [The principles of action and use of phlebotropic agents].
Kharkevich DA
Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390
[No Abstract] [Full Text] [Related]
19. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
Geroulakos G; Nicolaides AN
Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
[TBL] [Abstract][Full Text] [Related]
20. [Certain aspects of pathogenesis of hemorheological and trophic disturbances and their pharmacological correction in patients with chronic venous insufficiency].
Aliev SA; Ibishov KG; Aliev ES
Vestn Khir Im I I Grek; 2008; 167(2):39-43. PubMed ID: 18522184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
